Aug. 21 at 4:46 PM
Upcoming FDA catalyst watchlist:
$CAPR — Aug 22
Deramiocel FDA decision for Duchenne muscular dystrophy
$RARE — Aug 23
DTX401 FDA decision for GSDIa gene therapy
$BIIB — Aug 24
LEQEMBI IQLIK FDA decision for subcutaneous starting dose
$JAZZ /
$ZYME — Aug 25
Ziihera FDA decision for first-line HER2+ gastric/GEJ cancer
Big week of binary biotech catalysts ahead.
$CAPR and
$RARE are first up this weekend.
Which one are you watching?
